Navigation Links
Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
Date:4/26/2013

ALISO VIEJO, Calif., April 26, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for NUEDEXTA® (dextromethorphan hydrobromide and quinidine sulfate), recommending NUEDEXTA be approved for the treatment of pseudobulbar affect (PBA), irrespective of neurologic cause. In addition, the CHMP also recommended approval of two dose strengths of NUEDEXTA; 20/10 mg and 30/10 mg capsules.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

"The positive opinion from CHMP and recommendation for a broad PBA label for NUEDEXTA is a key step in the regulatory process toward having the first and only evidence-based treatment for PBA approved in the European Union," said Dr. Joao Siffert , chief scientific officer of Avanir. "We will continue to work with the European Medicines Agency and the European Commission toward the marketing authorization so that patients suffering from PBA have ready access to NUEDEXTA in Europe."

PBA is a neurologic condition characterized by outbursts of uncontrollable crying or laughing that are often contrary or exaggerated to the patient's inner mood state. As a result, many of those afflicted with PBA show significant impairment on standard measures of health status, and disruption in occupational and social function, often leading to social isolation. PBA occurs secondary to a variety of neurologic conditions such as traumatic brain injury (TBI), multiple sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease, stroke and Alzheimer's disease. When these disorders damage areas of the brain
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
2. AVANIR Pharmaceuticals To paticipate in two conferences in March
3. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
4. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
5. Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call
6. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
7. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
8. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
9. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
10. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
11. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
(Date:7/29/2014)... 29, 2014  Cloud Pharmaceuticals, Inc., a therapeutics ... announced today that it has been awarded a ... Small Business Innovation Research (NSF SBIR) program. The ... Cloud Pharmaceuticals designs new drugs and drug candidates ... innovative cloud computing technology in place of traditional ...
(Date:7/29/2014)... 29, 2014  Encision Inc. (OTCQB:ECIA), a medical device ... electrosurgical burns in minimally invasive surgery, today announced financial ... 30, 2014. The Company posted quarterly net ... of $202 thousand, or $(0.02) per share. These results ... net loss of $311 thousand, or $(0.04) per share, ...
Breaking Medicine Technology:A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000 2Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... 15, 2011  SuccessEHS announces the release of the new ... equip clients with a dependable roadmap to NCQA ... the meaningful use criteria. The release of ... solution that support the patient-centered care model, and underscores ...
... Dec. 15, 2011  New York Gov. Andrew Cuomo,s pen was ... law a bill that bans Pharmacy Benefit Managers (PBMs) from ... Cuomo and the New York State Assembly showed tremendous courage ... hundreds of thousands of dollars lobbying against the new law. ...
Cached Medicine Technology:SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 2SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 3SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 4New York's Anti-Mandatory Mail Order Law Underscores Growing Skepticism of PBMs 2
(Date:7/29/2014)... 29, 2014 A recent study ... journal Lipids in Health and Disease has added ... triglyceride-form best-selling Ultimate Omega®/ProOmega®. Consistently ranked as the ... scan data, the product was shown to be ... products in the marketplace. The goal of the ...
(Date:7/29/2014)... Bethesda, Maryland (PRWEB) July 29, 2014 ... has been named a 2014 ASAE Power of ... Flu-Focused," a public awareness campaign to encourage everyone age ... annually. , ASAE recognized NFID for its power ... drive awareness and action among consumers and professionals about ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Eleventh ... Venture Summit concluded with the $10,000 prize being presented ... ( http://www.bikanta.com ) , The 11th Annual Summit was ... with entrepreneurs who can bring innovative products and services ... are pleased to have had such excellent array of ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Oxnard dentists ... Anacapa Dental Art Institute in Oxnard and Woodland Hills, Calif., ... fallen out or been removed due to dental disease. , ... the two prosthodontists (experts in restoring and replacing teeth) want ... using implant specialists to perform their dental work and of ...
(Date:7/29/2014)... "Acceptance, Recognition, and Control (A.R.C.) Against Depression" ... demons and wants other men to heed the call to ... month later, he had no job, leaving Raymond with a ... the government for assistance, the emotional disturbance was so great ... this approach didn’t get to the root of his problems. ...
Breaking Medicine News(10 mins):Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 2Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 3Health News:National Foundation for Infectious Diseases Receives Top ASAE Honors for Keeping the Nation Flu-Focused 2Health News:Silicon Valley Boomer Venture Summit Names Bikanta Competition Winner 2Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 2Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 3Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 4Health News:SBPRA Announces the Release of Its Newest Title, "Acceptance, Recognition, and Control (A.R.C.) Against Depression" 2
... that parents who share their beds// with their newborn babies can ... infant death syndrome or SIDS is one of the major reasons ... month to a year. SIDS is a disorder that seems to ... risk factors that seem to increase the incidence of SIDS. ...
... a common condition in India where beetle and tobacco chewing ... certain bacteria’s excessive presence may give an early warning of ... in the Open Access journal, Journal of Translational Medicine has ... squamous cell carcinoma) have six common species of bacteria in ...
... women and the condition// can sometimes be fatal. Now researcher ... basal ganglia region of the brain. ,People with ... unaware of the seriousness of their condition.When you talk of ... talented singer Karen Carpenter who died in the prime of ...
... blood to indicate the possibility of heart// attack in people ... issue of New England Journal of Medicine indicates that blood ... fatty build- up patients have in their arteries of ... use of invasive tests like angiograms. ,Oxidized phospholipids ...
... study by the researchers of University of British Columbia had ... help to our concentration and efficiency, more so when that ... balance. ,Noise is often thought as the one sensation ... want to concentrate upon. Noise is often related to the ...
... good for health, especially the role of fats, had been ... University had found out that the between the various kinds ... to have the healthy meal by banishing one kind of ... The right combination of both can help achieve the best ...
Cached Medicine News:Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 3
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
2L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
Medicine Products: